2025-01-242026-01-312026-01-31false16206390SIMPLYPHARMA CONSULTING LIMITED2026-08-1270229falseiso4217:GBPxbrli:pure162063902025-01-23162063902026-01-31162063902025-01-242026-01-31162063902025-01-22162063902025-01-23162063902025-01-232025-01-2316206390bus:SmallEntities2025-01-242026-01-3116206390bus:AuditExempt-NoAccountantsReport2025-01-242026-01-3116206390bus:FullAccounts2025-01-242026-01-3116206390bus:PrivateLimitedCompanyLtd2025-01-242026-01-3116206390core:WithinOneYear2026-01-3116206390core:AfterOneYear2026-01-3116206390core:WithinOneYear2025-01-2316206390core:AfterOneYear2025-01-2316206390core:ShareCapital2026-01-3116206390core:SharePremium2026-01-3116206390core:RevaluationReserve2026-01-3116206390core:OtherReservesSubtotal2026-01-3116206390core:RetainedEarningsAccumulatedLosses2026-01-3116206390core:ShareCapital2025-01-2316206390core:SharePremium2025-01-2316206390core:RevaluationReserve2025-01-2316206390core:OtherReservesSubtotal2025-01-2316206390core:RetainedEarningsAccumulatedLosses2025-01-2316206390core:LandBuildings2026-01-3116206390core:PlantMachinery2026-01-3116206390core:Vehicles2026-01-3116206390core:FurnitureFittings2026-01-3116206390core:OfficeEquipment2026-01-3116206390core:NetGoodwill2026-01-3116206390core:IntangibleAssetsOtherThanGoodwill2026-01-3116206390core:ListedExchangeTraded2026-01-3116206390core:UnlistedNon-exchangeTraded2026-01-3116206390core:LandBuildings2025-01-2316206390core:PlantMachinery2025-01-2316206390core:Vehicles2025-01-2316206390core:FurnitureFittings2025-01-2316206390core:OfficeEquipment2025-01-2316206390core:NetGoodwill2025-01-2316206390core:IntangibleAssetsOtherThanGoodwill2025-01-2316206390core:ListedExchangeTraded2025-01-2316206390core:UnlistedNon-exchangeTraded2025-01-2316206390core:LandBuildings2025-01-242026-01-3116206390core:PlantMachinery2025-01-242026-01-3116206390core:Vehicles2025-01-242026-01-3116206390core:FurnitureFittings2025-01-242026-01-3116206390core:OfficeEquipment2025-01-242026-01-3116206390core:NetGoodwill2025-01-242026-01-3116206390core:IntangibleAssetsOtherThanGoodwill2025-01-242026-01-3116206390core:ListedExchangeTraded2025-01-242026-01-3116206390core:UnlistedNon-exchangeTraded2025-01-242026-01-3116206390core:MoreThanFiveYears2025-01-242026-01-3116206390core:Non-currentFinancialInstruments2026-01-3116206390core:Non-currentFinancialInstruments2025-01-2316206390dpl:CostSales2025-01-242026-01-3116206390dpl:DistributionCosts2025-01-242026-01-3116206390core:LandBuildings2025-01-242026-01-3116206390core:PlantMachinery2025-01-242026-01-3116206390core:Vehicles2025-01-242026-01-3116206390core:FurnitureFittings2025-01-242026-01-3116206390core:OfficeEquipment2025-01-242026-01-3116206390dpl:AdministrativeExpenses2025-01-242026-01-3116206390core:NetGoodwill2025-01-242026-01-3116206390core:IntangibleAssetsOtherThanGoodwill2025-01-242026-01-3116206390dpl:GroupUndertakings2025-01-242026-01-3116206390dpl:ParticipatingInterests2025-01-242026-01-3116206390dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-242026-01-3116206390core:ListedExchangeTraded2025-01-242026-01-3116206390dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-242026-01-3116206390core:UnlistedNon-exchangeTraded2025-01-242026-01-3116206390dpl:CostSales2025-01-232025-01-2316206390dpl:DistributionCosts2025-01-232025-01-2316206390core:LandBuildings2025-01-232025-01-2316206390core:PlantMachinery2025-01-232025-01-2316206390core:Vehicles2025-01-232025-01-2316206390core:FurnitureFittings2025-01-232025-01-2316206390core:OfficeEquipment2025-01-232025-01-2316206390dpl:AdministrativeExpenses2025-01-232025-01-2316206390core:NetGoodwill2025-01-232025-01-2316206390core:IntangibleAssetsOtherThanGoodwill2025-01-232025-01-2316206390dpl:GroupUndertakings2025-01-232025-01-2316206390dpl:ParticipatingInterests2025-01-232025-01-2316206390dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-232025-01-2316206390core:ListedExchangeTraded2025-01-232025-01-2316206390dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-232025-01-2316206390core:UnlistedNon-exchangeTraded2025-01-232025-01-2316206390core:NetGoodwill2026-01-3116206390core:IntangibleAssetsOtherThanGoodwill2026-01-3116206390core:LandBuildings2026-01-3116206390core:PlantMachinery2026-01-3116206390core:Vehicles2026-01-3116206390core:FurnitureFittings2026-01-3116206390core:OfficeEquipment2026-01-3116206390core:AfterOneYear2026-01-3116206390core:WithinOneYear2026-01-3116206390core:ListedExchangeTraded2026-01-3116206390core:UnlistedNon-exchangeTraded2026-01-3116206390core:ShareCapital2026-01-3116206390core:SharePremium2026-01-3116206390core:RevaluationReserve2026-01-3116206390core:OtherReservesSubtotal2026-01-3116206390core:RetainedEarningsAccumulatedLosses2026-01-3116206390core:NetGoodwill2025-01-2316206390core:IntangibleAssetsOtherThanGoodwill2025-01-2316206390core:LandBuildings2025-01-2316206390core:PlantMachinery2025-01-2316206390core:Vehicles2025-01-2316206390core:FurnitureFittings2025-01-2316206390core:OfficeEquipment2025-01-2316206390core:AfterOneYear2025-01-2316206390core:WithinOneYear2025-01-2316206390core:ListedExchangeTraded2025-01-2316206390core:UnlistedNon-exchangeTraded2025-01-2316206390core:ShareCapital2025-01-2316206390core:SharePremium2025-01-2316206390core:RevaluationReserve2025-01-2316206390core:OtherReservesSubtotal2025-01-2316206390core:RetainedEarningsAccumulatedLosses2025-01-2316206390core:NetGoodwill2025-01-2216206390core:IntangibleAssetsOtherThanGoodwill2025-01-2216206390core:LandBuildings2025-01-2216206390core:PlantMachinery2025-01-2216206390core:Vehicles2025-01-2216206390core:FurnitureFittings2025-01-2216206390core:OfficeEquipment2025-01-2216206390core:AfterOneYear2025-01-2216206390core:WithinOneYear2025-01-2216206390core:ListedExchangeTraded2025-01-2216206390core:UnlistedNon-exchangeTraded2025-01-2216206390core:ShareCapital2025-01-2216206390core:SharePremium2025-01-2216206390core:RevaluationReserve2025-01-2216206390core:OtherReservesSubtotal2025-01-2216206390core:RetainedEarningsAccumulatedLosses2025-01-2216206390core:AfterOneYear2025-01-242026-01-3116206390core:WithinOneYear2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:CostValuation2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-242026-01-3116206390core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3116206390core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3116206390core:Non-currentFinancialInstrumentscore:CostValuation2025-01-2316206390core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-2316206390core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-2316206390bus:Director12025-01-242026-01-31

SIMPLYPHARMA CONSULTING LIMITED

Registered Number
16206390
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2026

SIMPLYPHARMA CONSULTING LIMITED
Company Information
for the period from 24 January 2025 to 31 January 2026

Director

COSLET, Alexandra

Registered Address

Suite A
82 James Carter Road
Mildenhall
IP28 7DE

Registered Number

16206390 (England and Wales)
SIMPLYPHARMA CONSULTING LIMITED
Balance Sheet as at
31 January 2026

Notes

2026

£

£

Fixed assets
Tangible assets31,137
1,137
Current assets
Debtors413,660
Cash at bank and on hand7,959
21,619
Creditors amounts falling due within one year5(16,097)
Net current assets (liabilities)5,522
Total assets less current liabilities6,659
Provisions for liabilities6(216)
Net assets6,443
Capital and reserves
Called up share capital100
Profit and loss account6,343
Shareholders' funds6,443
The financial statements were approved and authorised for issue by the Director on 12 August 2026, and are signed on its behalf by:
COSLET, Alexandra
Director
Registered Company No. 16206390
SIMPLYPHARMA CONSULTING LIMITED
Notes to the Financial Statements
for the period ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Tangible fixed assets and depreciation
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Straight line (years)
Office Equipment3
2.Average number of employees

2026
Average number of employees during the year1
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions1,3181,318
At 31 January 261,3181,318
Depreciation and impairment
Charge for year181181
At 31 January 26181181
Net book value
At 31 January 261,1371,137
At 23 January 25--
4.Debtors: amounts due within one year

2026

£
Trade debtors / trade receivables4,572
Prepayments and accrued income9,088
Total13,660
5.Creditors: amounts due within one year

2026

£
Taxation and social security11,597
Other creditors3,500
Accrued liabilities and deferred income1,000
Total16,097
6.Provisions for liabilities

2026

£
Net deferred tax liability (asset)216
Total216
7.Directors advances, credits and guarantees
Included within creditors: amounts falling due within one year were loans from the director of £3500. The loans were interest free, with no fixed date for repayment.